Radiotherapy in painting dose on histoscannographic mapping for neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 13 Jul 2023: Trial registered, NCT05943119
  2. 11 Mar 2024: Trial started, NCT05943119

The trials

NCT05943119: Phase II Study of Intensity Modulated Radiotherapy in Dose Painting for Sinus Carcinomas After Endoscopic Surgery

State
Under way
Phase
Phase 2
People
52 planned
Started
11 Mar 2024
Primary completion
Jan 2028
Arms
Experimental group: Radiotherapy in painting dose on histoscannographic mapping
Results
None posted
  1. 13 Jul 2023: Trial registered
  2. 11 Mar 2024: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.